The Ca2+/calmodulin-dependent protein kinase kinase, CaMKK2, inhibits preadipocyte differentiation

Fumin Lin1, Thomas J Ribar, Anthony R Means

  • 1Department of Pharmacology and Cancer Biology, Duke University Medical School, Durham, North Carolina 27710, USA.

Endocrinology
|August 25, 2011
PubMed

Insights

Calcium/calmodulin-dependent protein kinase kinase 2 (CaMKK2) regulates fat cell differentiation. Inhibiting CaMKK2 in preadipocytes accelerates adipogenesis, impacting overall adiposity.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Metabolic Regulation

Background:

  • Ca(2+)/calmodulin-dependent protein kinase kinase 2 (CaMKK2) null mice exhibit increased adiposity and larger adipocytes on a standard diet.
  • Energy balance remains unchanged in these mice, suggesting a specific role for CaMKK2 in adipocyte biology.

Purpose of the Study:

  • To investigate the role of CaMKK2 in preadipocyte differentiation and adipogenesis.
  • To elucidate the signaling pathway involving CaMKK2 and AMP-activated protein kinase (AMPK) in regulating adiposity.

Main Methods:

  • CaMKK2 expression and function were analyzed in preadipocytes.
  • Experiments involved acute inhibition or genetic deletion of CaMKK2.
  • AMPK activation and its effect on differentiation were assessed.
  • Expression levels of key adipogenic genes (C/EBPβ, C/EBPδ, Preadipocyte factor 1, Sox9) were measured.

Main Results:

  • CaMKK2 is expressed in preadipocytes and acts as an AMPKα kinase.
  • Inhibition or deletion of CaMKK2 enhances preadipocyte differentiation into mature adipocytes.
  • Decreased CaMKK2 expression during adipogenesis correlates with increased C/EBPβ and C/EBPδ mRNA.
  • Inhibition of the CaMKK2/AMPK pathway reduces Preadipocyte factor 1 and Sox9, accelerating adipogenesis.

Conclusions:

  • CaMKK2 and AMPK are integral components of a signaling pathway that regulates adiposity.
  • This pathway plays a crucial role in controlling adipocyte differentiation and fat accumulation.

Related Concept Videos

Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...